This study explores how L-(+)-ergothioneine (LET) may improve endothelial dysfunction associated with preeclampsia by modulating the Nrf2-PPARγ-sFlt-1 axis. The findings suggest L…
The FDA has granted approval for Mounjaro (tirzepatide) to reduce cardiovascular risk in individuals with type 2 diabetes, marking a significant development in diabetes management…
A recent study explores the relationship between the Endothelial Activation and Stress Index (EASIX) and the estimated 10-year risk of atherosclerotic cardiovascular disease (ASCV…